Interestingly, both A2AR agonists and antagonists have shown beneficial effects [211]; thus, the potential exploitation of A2AR ligands in HD is still contentious, reflecting the complexity of A2AR regulation in this disease [132]. Here, ADORA2A is linked to Huntington disease.